PULMONX CORPORATION Debt Securities, Available-for-sale, Unrealized Loss Position
PULMONX CORPORATION (LUNG) had Debt Securities, Available-for-sale, Unrealized Loss Position of $5.72 million as of 2025-06-30, per its 10-Q filed 2025-08-01.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-03-10
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $5.72M.
- 2025-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $4.93M.
- 2024-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $5.66M.
- 2024-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $4.89M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2025-06-30 | $5.72M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $4.93M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $5.66M 10-K · filed 2026-03-10 |
| 2024-09-30 | $4.89M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $42.40M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $32.52M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $14.63M 10-K · filed 2025-02-25 |
| 2022-12-31 | $42.43M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |